A Phase 1 Study to Evaluate Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of Savolitinib in Healthy Male Volunteers

生物利用度 广告 药代动力学 尿 医学 药理学 排泄 口服 吸收(声学) 分布(数学) 内科学 数学分析 物理 数学 声学
作者
Kowser Miah,Karthick Vishwanathan,Graeme Scarfe,Yan Li,Indira Hara,Mireille Cantarini,John R. Argue,Somasekhar R. Menakuru
出处
期刊:Clinical pharmacology in drug development [Wiley]
卷期号:12 (4): 424-435 被引量:3
标识
DOI:10.1002/cpdd.1224
摘要

Abstract Savolitinib is an oral MET (hepatocyte growth factor receptor) tyrosine kinase inhibitor, with demonstrated preliminary efficacy in several cancer types. Previous pharmacokinetics assessments showed that savolitinib is rapidly absorbed but there are limited data on the absolute bioavailability and absorption, distribution, metabolism, and excretion (ADME) of savolitinib. This open‐label, two‐part, phase 1 clinical study (NCT04675021) used a radiolabeled micro‐tracer approach to evaluate absolute bioavailability and a traditional approach to determine the ADME of savolitinib in healthy male adult volunteers (N = 8). Pharmacokinetics, safety, and metabolic profiling and structural identification from plasma, urine, and fecal samples were also assessed. Volunteers received a single oral savolitinib 600 mg dose followed by intravenous 100 μg of [ 14 C]savolitinib in Part 1 and a single oral 300 mg [ 14 C]savolitinib dose (≤4.1 MBq [megabecquerel] [ 14 C]) in Part 2. Following Part 1, absolute oral bioavailability was 69%, the median time of maximum observed concentration was 3.5 hours, and the mean terminal half‐life was 6.1 hours. Following Part 2, 94% of the radioactivity administered was recovered, with 56% and 38% in urine and feces, respectively. Exposure to savolitinib and metabolites M8, M44, M2, and M3 accounted for 22%, 36%, 13%, 7%, and 2%, respectively, of plasma total radioactivity. Approximately 3% of the dose was excreted as unchanged savolitinib in urine. Most savolitinib elimination occurred via metabolism by several different pathways. No new safety signals were observed. Our data show that the oral bioavailability of savolitinib is high and the majority of savolitinib elimination occurs via metabolism and is excreted in the urine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
蓝天的应助被1vvvv采纳,获得10
1秒前
忐忑的惜寒完成签到,获得积分10
1秒前
1秒前
寄雨云中梦完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
DW的应助被冯梦梦采纳,获得10
1秒前
隐形曼青的应助被zc采纳,获得10
2秒前
故意的驳完成签到,获得积分10
2秒前
SciGPT的应助被yongqi采纳,获得10
2秒前
hhhh发布了新的文献求助10
2秒前
3秒前
3秒前
3秒前
彭于晏的应助被windli采纳,获得30
3秒前
传奇3的应助被windli采纳,获得30
3秒前
涟涵完成签到,获得积分10
3秒前
刘骁萱发布了新的文献求助10
3秒前
HHXXLL发布了新的文献求助10
3秒前
lpc完成签到 ,获得积分10
3秒前
2puerile发布了新的文献求助10
3秒前
hanahuang完成签到,获得积分10
4秒前
Dasiliy发布了新的文献求助10
4秒前
Lucas的应助被可乐采纳,获得10
4秒前
ffyz完成签到,获得积分20
4秒前
4秒前
快乐尔容完成签到,获得积分10
4秒前
绮梦yy关注了科研通微信公众号
5秒前
5秒前
别梦寒发布了新的文献求助10
5秒前
疯狂大蜗牛完成签到,获得积分10
5秒前
胡海龙发布了新的文献求助10
5秒前
6秒前
ericson完成签到,获得积分10
6秒前
6秒前
烟花的应助被细腻的惜珊采纳,获得10
6秒前
6秒前
qiulong发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162816
求助须知:如何正确求助?哪些是违规求助? 9557103
关于积分的说明 21738393
捐赠科研通 7753330
什么是DOI,文献DOI怎么找? 3427963
关于科研通互助平台的介绍 2552742
邀请新用户注册赠送积分活动 2472556